Literature DB >> 27184154

Combined pulsed dye and CO2 lasers in the treatment of angiolymphoid hyperplasia with eosinophilia.

Lior Sagi1, Shlomit Halachmi2, Assi Levi3, Dan Ben Amitai4,5, Claes D Enk6, Moshe Lapidoth7,5.   

Abstract

Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon dermatosis of unknown etiology that manifests as characteristic red nodules and papules with a predilection for the scalp and periauricular region. Treatment is required for both esthetic and functional reasons, as lesions may ulcerate and bleed. Many treatment approaches have been reported, including excision, systemic medical approaches, topical or intralesional therapies, and non-invasive modalities including cryotherapy, electrosurgery, and laser. Treatments have exhibited variable efficacy, and the recurrence rate is 100 %. We report the combination of pulsed dye laser and CO2 laser in the treatment of ALHE in 14 patients. All patients exhibited clinical response after a mean of 2.4 ± 0.4 treatment sessions. The clinical efficacy of the combined treatment, together with its well-tolerated nature, render the use of pulsed dye laser in combination with CO2 laser, a viable treatment for debulking ALHE lesions. Ongoing maintenance treatments are needed to due to the high degree of relapse.

Entities:  

Keywords:  Angiolymphoid hyperplasia; Carbon dioxide; Laser; Selective photothermolysis

Mesh:

Year:  2016        PMID: 27184154     DOI: 10.1007/s10103-016-1954-3

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  35 in total

1.  A case of angiolymphoid hyperplasia with eosinophilia treated with intralesional interferon alfa-2a.

Authors:  P D Shenefelt; M Rinker; S Caradonna
Journal:  Arch Dermatol       Date:  2000-07

2.  Eradication of angiolymphoid hyperplasia with eosinophilia by copper vapor laser.

Authors:  S W Fosko; D A Glaser; C J Rogers
Journal:  Arch Dermatol       Date:  2001-07

3.  Intralesional bleomycin for angiolymphoid hyperplasia.

Authors:  Necmettin Akdeniz; Mustafa Kösem; Omer Calka; Serap Günes Bilgili; Ahmet Metin; Ibrahim Gelincik
Journal:  Arch Dermatol       Date:  2007-07

4.  Angiolymphoid hyperplasia with eosinophilia of the scalp: promising results of long-pulsed tunable dye laser treatment.

Authors:  O Vanhooteghem; C Flagothier; M de la Brassinne
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-05-03       Impact factor: 6.166

5.  Nephrotic syndrome associated with Kimura's disease.

Authors:  T V Whelan; J F Maher; P Kragel; N Dysart; R Dannenhoffer; L Prager
Journal:  Am J Kidney Dis       Date:  1988-04       Impact factor: 8.860

6.  Subcutaneous angiolymphoid hyperplasia with eosinophilia.

Authors:  G C Wells; I W Whimster
Journal:  Br J Dermatol       Date:  1969-01       Impact factor: 9.302

7.  Subcutaneous angiolymphoid hyperplasia (Kimura disease). Report of a case.

Authors:  B H Kim; N Sithian; G F Cucolo
Journal:  Arch Surg       Date:  1975-10

8.  Treatment of angiolymphoid hyperplasia of the external ear with carbon dioxide laser.

Authors:  E R Hobbs; P L Bailin; J L Ratz; C L Yarbrough
Journal:  J Am Acad Dermatol       Date:  1988-08       Impact factor: 11.527

9.  Angiolymphoid hyperplasia with eosinophilia: removal with carbon dioxide laser in a patient on chronic oral anticoagulants.

Authors:  P G Hazen; J F Carney; E Evangelista
Journal:  Cutis       Date:  1989-08

10.  A Long-Term Follow-Up of Angiolymphoid Hyperplasia with Eosinophilia Treated by Corticosteroids: When a Traditional Therapy is Still Up-to-Date.

Authors:  Serena Lembo; Anna Balato; Teresa Cirillo; Nicola Balato
Journal:  Case Rep Dermatol       Date:  2011-03-05
View more
  1 in total

1.  Novel Application of 32P Brachytherapy: Treatment of Angiolymphoid Hyperplasia with Eosinophilia in the Right Auricle with 8-Year Follow-Up.

Authors:  Jinshan Zhang; Yuan Li; Ge Wen; Yongmei Deng; Hongxia Yao
Journal:  Cancer Biother Radiopharm       Date:  2018-06-29       Impact factor: 3.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.